La sindrome di Pearson

1. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979;95(6):976-84. 2. Rötig A, Collonna M, Bonnefont JP, et al. Mitochondrial DNA deletion in Pearson’s marrow/pancreas syndrome. Lancet 1989;1 (8643):902-3. 3. Rötig A, Cormier V, Blanche S, et al. Pearson’s marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 1990;86(5):1601-8. 4. Rötig A, Bourgeron T, Chretien D, Rustin P, Munnich A. Spectrum of mitochondrial DNA rearrangements in the Pearson marrow- pancreas syndrome. Hum Mol Genet 1995;4:1327-30. 5. Broomfield A, Sweeney MG, Woodward CE, et al. Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease. J Inherit Metab Dis 2015;38 (3):445-57. 6. Farruggia P, Di Cataldo A, Pinto RM, et al. Pearson Syndrome: a retrospective cohort study from the marrow failure study group of AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). JIMD Rep 2016;26:37-43. 7. Gorman GS, Schaefer AM, Ng Y, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol 2015;77(5):753-9. 8. Chinnery PF, Johnson MA, Wardell TM, et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 2000;48 (2):188-93. 9. Chinnery PF, Turnbull DM. Epidemiology and treatment of mitochondrial disorders. Am J Med Genet 2001;106(1):94-101. 10. Giles RE, Blanc H, Cann HM, Wallace DC. Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci USA 1980;77(11):6715-9. 11. Rötig A, Poulton J. Genetic causes of mitochondrial DNA depletion in humans. Biochim Biophys Acta 2009;1792(12):1103-8. 12. Tuppen HA, Blakely EL, Turnbull DM, Taylor RW. Mitochondrial DNA deletions and human disease. Biochim Biophys Acta 2010; 1797(2):113-28. 13. Haigis MC, Yankner BA. The aging stress response. Mol Cell 2010;40(2):333-44. 14. Krishnan KJ, Reeve AK, Samuels DC, et al. What causes mitochondrial DNA deletions in human cells? Nat Genet 2008;40(3):275-9. 15. Schon EA, Di Mauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet 2012;13(12): 878-90. 16. Kisler JE, Whittaker RG, McFarland R. Mitochondrial diseases in childhood: a clinical approach to investigation and management. Dev Med Child Neurol 2010;52(5):422-33. 17. Mita S, Rizzuto R, Moraes CT, et al. Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucleic Acids Res 1990; 18(3):561-7. 18. Thorburn DR, Dahl HH. Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options. Am J Med Genet 2001;106(1):102-14. 19. Chen X, Prosser R, Simonetti S, Sadlock J, Jagiello G, Schon EA. Rearranged mitochondrial genomes are present in human oocytes. Am J Hum Genet 1995;57(2):239-47. 20. Bernes SM, Bacino C, Prezant TR, et al. Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome. J Pediatr 1993;123(4):598-602. 21. Shanske S, Tang Y, Hirano M, et al. Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with Pearson syndrome. Am J Hum Genet 2002;71 (3):679-83. 22. Ozawa T, Yoneda M, Tanaka M, et al. Maternal inheritance of deleted mitochondrial DNA in a family with mitochondrial myopathy. Biochem Biophys Res Commun 1988; 154(3):1240-7. 23. Larsson NG, Holme E, Kristiansson B, Oldfors A, Tulinius M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 1990;28 (2):131-6. 24. Jokinen R, Marttinen P, Sandell HK, et al. Gimap3 regulates tissue-specific mitochondrial DNA segregation. PLoS Genet 2010;6 (10):e1001161. 25. Marchington DR, Macaulay V, Hartshorne GM, Barlow D, Poulton J. Evidence from human oocytes for a genetic bottleneck in an mtDNA disease. Am J Hum Genet 1998;63 (3):769-75. 26. Graff C, Wredenberg A, Silva JP, Bui TH, Borg K, Larsson NG. Complex genetic counselling and prenatal analysis in a woman with external ophthalmoplegia and deleted mtDNA. Prenat Diagn 2000;20(5):426-31. 27. Gussi IL, Rahimian H, Stanescu Popp AM. Prenatal features of an uncommon specific mitochondrial cytopathy - the Pearson syndrome. Ultrasound in Obstetrics & Gynecology 2009;34 (Suppl. 1):177-284. 28. Fellman V, Kotarsky H. Mitochondrial hepatopathies in the newborn period. Semin Fetal Neonatal Med 2011;16(4):222-8. 29. Manea EM, Leverger G, Bellmann F, et al. Pearson syndrome in the neonatal period: two case reports and review of the literature. J Pediatr Hematol Oncol 2009;31(12):947-51. 30. Lohi O, Kuusela AL, Arola M. A novel deletion in a Pearson syndrome infant with hypospadias and cleft lip and palate. J Inherit Metab Dis 2005;28(6):1165-6. 31. Gürgey A, Ozalp I, Rötig A, et al. A case of Pearson syndrome associated with multiple renal cysts. Pediatr Nephrol 1996;10(5):637-8. 32. Munakata K, Bundo M, Kato T, et al. Coexisting point mutations of mitochondrial DNA in a patient with a heart abnormality and Pearson syndrome-like symptoms. Am J Med Genet A 2005;139A(2):162-4. 33. Pathak S, Sethi A, Gupta N, Ranasaria M. Proximal renal tubular acidosis due to mitochondrial cytopathy: a case report. IJRRMS 2014;4(3):23-7. 34. Morel AS, Joris N, Meuli R, et al. Early neurological impairment and severe anemia in a newborn with Pearson syndrome. Eur J Pediatr 2009;168(3):311-5. 35. Mancuso M, Orsucci D, Angelini C, et al. Redefining phenotypes associated with mitochondrial DNA single deletion. J Neurol 2015;262(5):1301-9. 36. Crippa BL, Leon E, Calhoun A, Lowichik A, Pasquali M, Longo N. Biochemical abnormalities in Pearson syndrome. Am J Med Genet A 2015;167°(3):621-8. 37. Williams TB, Daniels M, Puthenveetil G, Chang R, Wang RY, Abdenur JE. Pearson syndrome: unique endocrine manifestations including neonatal diabetes and adrenal insufficiency. Mol Genet Metab 2012;106(1):104-7. 38. Atale A, Bonneau-Amati P, Rötig A, et al. Tubulopathy and pancytopaenia with normal pancreatic function: a variant of Pearson syndrome. Eur J Med Genet 2009;52(1):23-6. 39. Inoue S, Yokota M, Nakada K, Miyoshi H, Hayashi J. Pathogenic mitochondrial DNA-induced respiration defects in hematopoietic cells result in anemia by suppressing erythroid differentiation. FEBS Lett 2007;581(9): 1910-6. 40. Gümrük F, Kuşkonmaz B, Coşkun T. Pearson syndrome associated with hemophagocytic syndrome in a child. Turk J Haematol 2008;25(1):54-5. 41. Gagne KE, Ghazvinian R, Yuan D, et al. Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia. Blood 2014;124(3):437-40. 42. Hoyoux C, Dresse MF, Robinet S, et al. Cord blood transplantation in a child with Pearson’s disease. Pediatr Blood Cancer 2008;51(4):566. 43. Tumino M, Meli C, Farruggia P, et al. Clinical manifestations and management of four children with Pearson syndrome. Am J Med Genet A 2011;155A(12):3063-6. 44. Santorelli FM, Barmada MA, Pons R, Zhang LL, DiMauro S. Leigh-type neuropathology in Pearson syndrome associated with impaired ATP production and a novel mtDNA deletion. Neurology 1996;47(5):1320- 3. 45. Momont AC, Trobe JD. Transient corneal edema and left hemisphere dysfunction in Pearson syndrome. J Neuroophthalmol 2009; 29(2):158-9. 46. Cursiefen C, Küchle M, Scheurlen W, Naumann GO. Bilateral zonular cataract associated with the mitochondrial cytopathy of Pearson syndrome. Am J Ophthalmol 1998; 125(2):260-1. 47. Arzanian MT, Eghbali A, Karimzade P, Ahmadi M, Houshmand M, Rezaei N. mtDNA deletion in an Iranian infant with Pearson marrow syndrome. Iran J Pediatr 2010;20(1): 107-12. 48. Lacbawan F, Tifft CJ, Luban NL, et al. Clinical heterogeneity in mitochondrial DNA deletion disorders: a diagnostic challenge of Pearson syndrome. Am J Med Genet 2000;95 (3):266-8. 49. Gibson KM, Bennett MJ, Mize CE, et al. 3-Methylglutaconic aciduria associated with Pearson syndrome and respiratory chain defects. J Pediatr 1992;121(6):940-2. 50. Lichter-Konecki U, Trefz FK, Rötig A, Munnich A, Pfeil A, Bremer HJ. 3-Methylglutaconic aciduria in a patient with Pearson syndrome. Eur J Pediatr 1993;152(4):378. 51. Sanderson S, Green A, Preece MA, Burton H. The incidence of inherited metabolic disorders in the West Midlands, UK. Arch Dis Child 2006;91(11):896-9. 52. Superti-Furga A, Schoenle E, Tuchschmid P, et al. Pearson bone marrow-pancreas syndrome with insulin-dependent diabetes, progressive renal tubulopathy, organic aciduria and elevated fetal haemoglobin caused by deletion and duplication of mitochondrial DNA. Eur J Pediatr 1993;152(1):44-50. 53. Aljurf M, Gluckman E, Dufour C (Eds). Severe congenital neutropenias and other rare congenital marrow failures. In: Congenital and acquired bone marrow failures. Elsevier, 2017. 54. Faraci M, Cuzzubbo D, Micalizzi C, et al. Allogeneic bone marrow transplantation for Pearson’s syndrome. Bone Marrow Transplant 2007;39(9):563-5. 55. Seneca S, De Meirleir L, De Schepper J, et al. Pearson marrow pancreas syndrome: a molecular study and clinical management. Clin Genet 1997;51(5):338-42. 56. Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R, Medicine Society TM. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 2009;11(6):414-30. 57. Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science 1999;285(5432):1390-3.